Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSherborne Inv C Regulatory News (SIGC)

Share Price Information for Sherborne Inv C (SIGC)

Share Price is delayed by 15 minutes
Get Live Data
32.20    0.00 (0.00%)
Bid:
31.40
Ask:
33.00
Spread: 1.60 (5.096%)
Market Cap: £208.46m
SIGC Live PriceLast checked at - London Stock Exchange

Intraday Sherborne Inv C Share Chart

Statement re Investment Update

7 May 2021 07:00

RNS Number : 8512X
Sherborne Investors (Guernsey)C Ltd
07 May 2021
 

Sherborne Investors (Guernsey) C Limited

LEI 213800L8QL59OCFOCB40

This announcement contains inside information

7 May 2021

 

Sherborne Investors (Guernsey) C Limited

Investment Update

 

 

The board of Sherborne Investors (Guernsey) C Limited (the "Company") has been notified by Sherborne Investors Management LP ("Sherborne Investors") that funds managed by it have disposed of their entire 6.01% shareholding in Barclays PLC ("Barclays").

 

Sherborne Investors has informed the Company that it believes that the risk of and rewards from a new investment opportunity that it has identified offers a better return to the Company's shareholders than a continuing investment in Barclays. As provided for in the partnership agreement of SIGC, LP (Incorporated) (the "Partnership") and the Company's investment process as set out in its prospectus, the independent board of the Company (the "Board") has reviewed Sherborne Investors' recommendation of a new investment and, following Board approval, Sherborne Investors has initiated investment into securities of the new target company.

 

Sherborne Investors has advised the Company that its turnaround assumptions indicate a potential return on the investment in line with Sherborne Investors' customary return objectives, and the investment thesis underlying this will be discussed with shareholders once a disclosable shareholding has been accumulated.

 

Sherborne Investors manages funds for various clients, including the Partnership, a limited partnership in which the Company has invested. Sherborne Investors is the parent of Sherborne Investors Management (Guernsey) LLC, the investment manager of the Partnership.

 

Giving effect to the transactions, the current Net Asset Value of the Company is approximately £550 million, or 79p per share.

 

The person responsible for making this announcement is Nick Robilliard of Apex Fund and Corporate Services (Guernsey) Limited ("Apex"), Company Secretary.

 

-Ends-

 

Enquiries: 

 

FTI Consulting +44 (0)20 3727 1000

Jonathon Brill

James Styles

 

Numis Securities Limited (Broker) +44 (0)20 7260 1000

David Benda

Nathan Brown

 

Sherborne Investors (Guernsey) C Limited +44 (0)14 8173 5827

Talmai Morgan (Chairman)

Nick Robilliard (Apex, Company Secretary)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STREADSKEDEFEAA
Date   Source Headline
1st Jun 20267:00 amRNSNet Asset Value(s)
1st Jun 20267:00 amRNSTotal Voting Rights
22nd May 20263:36 pmRNSResult of AGM
19th May 20267:00 amRNSNotice of AGM
1st May 20267:00 amRNSNet Asset Value(s)
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSNotice of AGM and Rule 9 Waiver
29th Apr 20267:00 amRNSDividend Declaration
29th Apr 20267:00 amRNSAnnual Financial Report
29th Apr 20267:00 amRNSPublication of Annual Report
1st Apr 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20265:00 pmRNSHolding(s) in Company
2nd Feb 20267:00 amRNSNet Asset Value(s)
30th Jan 20265:00 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSNet Asset Value(s)
1st Dec 20257:00 amRNSNet Asset Value(s)
1st Dec 20257:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSNet Asset Value(s)
3rd Nov 20257:00 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSNet Asset Value(s)
1st Oct 20257:00 amRNSTotal Voting Rights
4th Sep 20257:00 amRNSHalf-year Report
1st Sep 20257:00 amRNSNet Asset Value(s)
1st Sep 20257:00 amRNSTotal Voting Rights
27th Aug 20257:00 amRNSDirectorate Change
1st Aug 20257:00 amRNSNet Asset Value(s)
1st Aug 20257:00 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSNet Asset Value(s)
1st Jul 20257:00 amRNSTotal Voting Rights
4th Jun 20254:24 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSNet Asset Value(s)
2nd Jun 20257:00 amRNSTotal Voting Rights
21st May 20254:32 pmRNSResult of AGM
6th May 20257:00 amRNSDirectorate Change
1st May 20257:00 amRNSNet Asset Value(s)
23rd Apr 20257:00 amRNSNotice of AGM and Rule 9 Waiver
23rd Apr 20257:00 amRNSDividend Declaration
23rd Apr 20257:00 amRNSAnnual Financial Report
23rd Apr 20257:00 amRNSPublication of Annual Report
1st Apr 20257:00 amRNSNet Asset Value(s)
3rd Mar 20257:00 amRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSNet Asset Value(s)
2nd Jan 20257:00 amRNSNet Asset Value(s)
2nd Dec 20247:00 amRNSNet Asset Value(s)
6th Nov 20246:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.